medmix AG (MEDX) Price & Analysis

Compare

1 Followers

MEDX Stock Chart & Stats

CHF8.92

CHF0.32(2.96%)

At close: Mar 06 4:00 PM EST

CHF8.92

CHF0.32(2.96%)

Day’s Range― - ―

52-Week RangeCHF8.18 - CHF13.02

Previous CloseN/A

Volume22.50K

Average Volume (3M)115.75K

Market Cap

CHF364.76M

Enterprise ValueCHF645.95M

Total Cash (Recent Filing)CHF113.90M

Total Debt (Recent Filing)CHF391.90M

Price to Earnings (P/E)71.6

Beta1.07

Next Earnings

Jul 16, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield4.54%

Share Statistics

EPS (TTM)0.33

Shares Outstanding41,262,370

10 Day Avg. Volume183,978

30 Day Avg. Volume115,752

Financial Highlights & Ratios

PEG Ratio-0.38

Price to Book (P/B)1.08

Price to Sales (P/S)1.02

P/FCF Ratio13.76

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

CHF16.00

Price Target Upside79.37% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)0.7

Revenue Forecast (FY)CHF464.37M

Bulls Say, Bears Say

Bulls Say

Recurring Consumables And Installed-base Revenuemedmix’s business model includes high-repeat consumables tied to installed dispensing equipment. This creates a durable annuity-like revenue stream as customers repurchase tips and single-use components, supporting steady demand and higher lifetime value per customer once systems are specified.

Positive Free Cash Flow GenerationSustained positive free cash flow, even after a sharp YoY decline, indicates the company generates internal resources to fund operations, service debt, and support strategic projects. Reliable cash generation enhances financial flexibility and reduces reliance on external financing over the medium term.

Diversified Industrial And Healthcare End MarketsServing both industrial and healthcare customers plus providing hardware, consumables, and engineering services spreads revenue risk across sectors. Healthcare program wins can convert to multi-year supply contracts, while industrial specifications drive steady consumable demand, improving revenue resilience.

Bears Say

Revenue Weakness And Recent DeclinesRecent revenue declines indicate demand softness and limit operating leverage. With top-line stagnation, the company faces pressure to grow organically or win large programs to restore scale; prolonged revenue weakness constrains margin recovery and reinvestment capacity.

Thin Profitability And Low ReturnsVery low net margins and weak ROE imply the business currently converts little of revenue into shareholder returns. This limits internal capital for R&D, capex, or payouts, and provides a thin buffer against cost shocks, making sustained margin improvement essential for durable financial health.

Rising Leverage Reduces Financial FlexibilityDebt approaching parity with equity increases fixed obligations and reduces flexibility for strategic investments or payouts. Higher leverage elevates refinancing and interest-rate risk, constraining the company’s ability to pursue growth initiatives or absorb cyclical downturns without pressuring cash flow.

medmix AG News

Medmix Lifts Margins and Returns to Profit Amid Revenue Decline and Strategic Shift to Healthcare

The latest announcement is out from medmix AG ( ($CH:MEDX) ). Medmix reported 2025 revenue down 4.8% organically...

17d ago

MEDX

medmix Expands Global Beauty Market Presence with New Facilities

medmix AG ( ($CH:MEDX) ) has issued an update. medmix Group has bolstered its presence in key global...

5M ago

MEDX

medmix AG Partners with Gurit for Sustainable Bonding Solutions

medmix AG ( ($CH:MEDX) ) has issued an update. medmix AG has announced a strategic partnership with Gurit...

6M ago

MEDX

medmix AG Reports Increased Profitability Amid Revenue Decline in H1 2025

medmix AG ( ($CH:MEDX) ) has shared an announcement. medmix AG reported a 6.5% decline in revenue for...

8M ago

MEDX

medmix AG Achieves Top Climate Leadership Recognition

medmix AG ( ($CH:MEDX) ) has shared an update. medmix AG has been recognized as one of only...

10M ago

MEDX

medmix Shareholders Approve Board Proposals and Dividend at AGM 2025

An announcement from medmix AG ( ($CH:MEDX) ) is now available. At the annual general meeting of medmix...

11M ago

MEDX

MEDX FAQ

What was medmix AG’s price range in the past 12 months?

medmix AG lowest stock price was CHF8.18 and its highest was CHF13.02 in the past 12 months.

What is medmix AG’s market cap?

medmix AG’s market cap is CHF364.76M.

When is medmix AG’s upcoming earnings report date?

medmix AG’s upcoming earnings report date is Jul 16, 2026 which is in 123 days.

How were medmix AG’s earnings last quarter?

medmix AG released its earnings results on Feb 26, 2026. The company reported CHF0.33 earnings per share for the quarter, the consensus estimate of CHF0.33 by CHF0.

Is medmix AG overvalued?

According to Wall Street analysts medmix AG’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does medmix AG pay dividends?

medmix AG pays a Annually dividend of CHF0.5 which represents an annual dividend yield of 4.54%. See more information on medmix AG dividends here

What is medmix AG’s EPS estimate?

medmix AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does medmix AG have?

medmix AG has 41,262,370 shares outstanding.

What happened to medmix AG’s price movement after its last earnings report?

medmix AG reported an EPS of CHF0.33 in its last earnings report, expectations of CHF0.33. Following the earnings report the stock price went down -14.851%.

Which hedge fund is a major shareholder of medmix AG?

Currently, no hedge funds are holding shares in CH:MEDX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

medmix AG

Medmix AG designs, develops, manufactures, and delivers high-precision devices and services for the mixing, application, and injection of liquids in a range of viscosities for the healthcare, consumer, and industrial end markets worldwide. It operates through five segments: Dental, Drug Delivery, Surgery, Industry, and Beauty. The Dental segment offers mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, restorations, anesthetics, and aesthetics. The Drug Delivery segment offers drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases. The Surgery segment provides mixing and delivery devices which are used to inject bone cement, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. The Industry segment produces and markets dispensers, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics, infrastructure, and general industrial sectors. The Beauty segment offers micro brushes, mascara, lip gloss and concealers. The company offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. The company was founded in 1922 and is based in Zug, Switzerland.

medmix AG (MEDX) Earnings & Revenues

Historic Earnings Reports

MEDX Stock 12 Month Forecast

Average Price Target

CHF16.00

▲(79.37% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"CHF7","12":"CHF12","17":"CHF17","9.5":"CHF9.5","14.5":"CHF14.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF16.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF16.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF16.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,9.5,12,14.5,17],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.42,9.926153846153847,10.432307692307692,10.938461538461539,11.444615384615386,11.95076923076923,12.456923076923077,12.963076923076922,13.46923076923077,13.975384615384616,14.481538461538461,14.987692307692308,15.493846153846153,{"y":16,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.42,9.926153846153847,10.432307692307692,10.938461538461539,11.444615384615386,11.95076923076923,12.456923076923077,12.963076923076922,13.46923076923077,13.975384615384616,14.481538461538461,14.987692307692308,15.493846153846153,{"y":16,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.42,9.926153846153847,10.432307692307692,10.938461538461539,11.444615384615386,11.95076923076923,12.456923076923077,12.963076923076922,13.46923076923077,13.975384615384616,14.481538461538461,14.987692307692308,15.493846153846153,{"y":16,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.01,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":8.37,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":11.68,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":10.67,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":10.67,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.7,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.96,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.84,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.8,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":9.22,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":11.24,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 43, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":11.48,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 53, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":9.42,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 43, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >